ISSN: 0270-9139

Journal Home

Journal Guideline

Hepatology Q1 Unclaimed

John Wiley and Sons Ltd United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hepatology is a journal indexed in SJR in Medicine (miscellaneous) and Hepatology with an H index of 361. It has a price of 1900 €. It has an SJR impact factor of 5,488 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,488.

Hepatology focuses its scope in these topics and keywords: hepatitis, virus, liver, patients, chronic, cells, hepatocellular, factor, infection, growth, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Hepatology (Q1) Medicine (miscellaneous) (Q1)

Price

1900 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

5,488

SJR Impact factor

361

H Index

501

Total Docs (Last Year)

1612

Total Docs (3 years)

14907

Total Refs

14033

Total Cites (3 years)

1062

Citable Docs (3 years)

9,04

Cites/Doc (2 years)

29,75

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Drug Discovery Q1
Annual Review of Pathology: Mechanisms of Disease Q1
NCHS data brief Q1
Molecular Systems Biology Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

1204 Early HCV kinetics in immunosuppressed patients undergoing antiviral therapy: OLT vs. HIV-HCV coinfected vs. normal patients

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection

Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease

Hepatitis C in asymptomatic blood donors

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

Advances in bioartificial liver devices

Liver failure in children with hepatitis A

Induction of interleukin-6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C

Viral kinetics and hepatitis C

Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with anmdr1agene disruption

The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A

Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C

SHOW MORE ARTICLES

The role of TT virus infection in acute viral hepatitis

Results of retransplantation for recurrent hepatitis C

Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma

Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C

Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma

Critical flicker frequency for quantification of low-grade hepatic encephalopathy

Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats

Determining the fate of hepatic cells by lineage tracing: Facts and pitfalls

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

L-ornithine L-aspartate in bouts of overt hepatic encephalopathy